Sierra Leone Reports First Mpox Cases as DRC Accelerates Vaccine Drive 16/01/2025 Paul Adepoju A new mpox outbreak in Sierra Leone and a rising case toll across Africa are fueling urgent calls for stronger containment efforts, even as the Democratic Republic of Congo (DRC) finally speeds up its mpox vaccine drive and Rwanda’s swift response to Marburg suggests a model for epidemic control. Health authorities in Sierra Leone have […] Continue reading -> Pakistan’s New Commitment to End Hepatitis Needs a People-Centered Approach 11/01/2025 Nida Ali Picture a young woman in rural Sindh in Pakistan, fatigued from years of battling an undiagnosed illness, unable to care for her children or fulfill her potential. But a simple diagnostic test and a 12-week treatment for hepatitis C could transform and save her life. This story is no longer a distant dream. With the […] Continue reading -> Third of Nations Collect No Air Quality Data, Masking Health Risks for One Billion People 13/12/2024 Stefan Anderson More than one-third of countries worldwide lack government-level air quality monitoring, leaving nearly one billion people in the dark about one of the greatest risks to their health, a new report showed on Friday. The assessment by non-profit OpenAQ, which maintains the largest open-source database of air quality measurements, found significant gaps in government tracking […] Continue reading -> African Research Partners Consolidate Network to Accelerate Continental Drug Discovery 10/12/2024 Elaine Ruth Fletcher Nearly two decades ago, South African researcher Kelly Chibale recalls participating in a pioneering World Health Organization (WHO) meeting in Abuja, Nigeria, organized by TDR, the WHO-hosted Special Programme for Research and Training in Tropical Diseases, focusing on the concept of an African drug discovery network. For Chibale, the main outcome of that encounter was […] Continue reading -> Pharmaceutical Industry’s Medicine Access Efforts Stall in Poor Nations, Watchdog Finds 21/11/2024 Stefan Anderson Major pharmaceutical companies have made minimal progress in expanding access to essential medicines since the COVID-19 pandemic, according to an industry watchdog report released Tuesday. The 2024 Access to Medicine Index, which evaluates 20 of the world’s leading drugmakers, found that despite modest improvements from certain companies, the overall pace of change in improving availability […] Continue reading -> Sustainability is the Focus of WHO’s mRNA Vaccine Programme as Partners Look Beyond COVID 20/11/2024 Kerry Cullinan CAPE TOWN – Sustainability is the priority for vaccine manufacturers that are part of the mRNA technology transfer programme established by the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The programme was launched in 2020 to equip low and middle-income countries (LMIC) to make their own COVID-19 vaccines to address the inequity […] Continue reading -> Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
Pakistan’s New Commitment to End Hepatitis Needs a People-Centered Approach 11/01/2025 Nida Ali Picture a young woman in rural Sindh in Pakistan, fatigued from years of battling an undiagnosed illness, unable to care for her children or fulfill her potential. But a simple diagnostic test and a 12-week treatment for hepatitis C could transform and save her life. This story is no longer a distant dream. With the […] Continue reading -> Third of Nations Collect No Air Quality Data, Masking Health Risks for One Billion People 13/12/2024 Stefan Anderson More than one-third of countries worldwide lack government-level air quality monitoring, leaving nearly one billion people in the dark about one of the greatest risks to their health, a new report showed on Friday. The assessment by non-profit OpenAQ, which maintains the largest open-source database of air quality measurements, found significant gaps in government tracking […] Continue reading -> African Research Partners Consolidate Network to Accelerate Continental Drug Discovery 10/12/2024 Elaine Ruth Fletcher Nearly two decades ago, South African researcher Kelly Chibale recalls participating in a pioneering World Health Organization (WHO) meeting in Abuja, Nigeria, organized by TDR, the WHO-hosted Special Programme for Research and Training in Tropical Diseases, focusing on the concept of an African drug discovery network. For Chibale, the main outcome of that encounter was […] Continue reading -> Pharmaceutical Industry’s Medicine Access Efforts Stall in Poor Nations, Watchdog Finds 21/11/2024 Stefan Anderson Major pharmaceutical companies have made minimal progress in expanding access to essential medicines since the COVID-19 pandemic, according to an industry watchdog report released Tuesday. The 2024 Access to Medicine Index, which evaluates 20 of the world’s leading drugmakers, found that despite modest improvements from certain companies, the overall pace of change in improving availability […] Continue reading -> Sustainability is the Focus of WHO’s mRNA Vaccine Programme as Partners Look Beyond COVID 20/11/2024 Kerry Cullinan CAPE TOWN – Sustainability is the priority for vaccine manufacturers that are part of the mRNA technology transfer programme established by the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The programme was launched in 2020 to equip low and middle-income countries (LMIC) to make their own COVID-19 vaccines to address the inequity […] Continue reading -> Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
Third of Nations Collect No Air Quality Data, Masking Health Risks for One Billion People 13/12/2024 Stefan Anderson More than one-third of countries worldwide lack government-level air quality monitoring, leaving nearly one billion people in the dark about one of the greatest risks to their health, a new report showed on Friday. The assessment by non-profit OpenAQ, which maintains the largest open-source database of air quality measurements, found significant gaps in government tracking […] Continue reading -> African Research Partners Consolidate Network to Accelerate Continental Drug Discovery 10/12/2024 Elaine Ruth Fletcher Nearly two decades ago, South African researcher Kelly Chibale recalls participating in a pioneering World Health Organization (WHO) meeting in Abuja, Nigeria, organized by TDR, the WHO-hosted Special Programme for Research and Training in Tropical Diseases, focusing on the concept of an African drug discovery network. For Chibale, the main outcome of that encounter was […] Continue reading -> Pharmaceutical Industry’s Medicine Access Efforts Stall in Poor Nations, Watchdog Finds 21/11/2024 Stefan Anderson Major pharmaceutical companies have made minimal progress in expanding access to essential medicines since the COVID-19 pandemic, according to an industry watchdog report released Tuesday. The 2024 Access to Medicine Index, which evaluates 20 of the world’s leading drugmakers, found that despite modest improvements from certain companies, the overall pace of change in improving availability […] Continue reading -> Sustainability is the Focus of WHO’s mRNA Vaccine Programme as Partners Look Beyond COVID 20/11/2024 Kerry Cullinan CAPE TOWN – Sustainability is the priority for vaccine manufacturers that are part of the mRNA technology transfer programme established by the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The programme was launched in 2020 to equip low and middle-income countries (LMIC) to make their own COVID-19 vaccines to address the inequity […] Continue reading -> Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
African Research Partners Consolidate Network to Accelerate Continental Drug Discovery 10/12/2024 Elaine Ruth Fletcher Nearly two decades ago, South African researcher Kelly Chibale recalls participating in a pioneering World Health Organization (WHO) meeting in Abuja, Nigeria, organized by TDR, the WHO-hosted Special Programme for Research and Training in Tropical Diseases, focusing on the concept of an African drug discovery network. For Chibale, the main outcome of that encounter was […] Continue reading -> Pharmaceutical Industry’s Medicine Access Efforts Stall in Poor Nations, Watchdog Finds 21/11/2024 Stefan Anderson Major pharmaceutical companies have made minimal progress in expanding access to essential medicines since the COVID-19 pandemic, according to an industry watchdog report released Tuesday. The 2024 Access to Medicine Index, which evaluates 20 of the world’s leading drugmakers, found that despite modest improvements from certain companies, the overall pace of change in improving availability […] Continue reading -> Sustainability is the Focus of WHO’s mRNA Vaccine Programme as Partners Look Beyond COVID 20/11/2024 Kerry Cullinan CAPE TOWN – Sustainability is the priority for vaccine manufacturers that are part of the mRNA technology transfer programme established by the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The programme was launched in 2020 to equip low and middle-income countries (LMIC) to make their own COVID-19 vaccines to address the inequity […] Continue reading -> Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
Pharmaceutical Industry’s Medicine Access Efforts Stall in Poor Nations, Watchdog Finds 21/11/2024 Stefan Anderson Major pharmaceutical companies have made minimal progress in expanding access to essential medicines since the COVID-19 pandemic, according to an industry watchdog report released Tuesday. The 2024 Access to Medicine Index, which evaluates 20 of the world’s leading drugmakers, found that despite modest improvements from certain companies, the overall pace of change in improving availability […] Continue reading -> Sustainability is the Focus of WHO’s mRNA Vaccine Programme as Partners Look Beyond COVID 20/11/2024 Kerry Cullinan CAPE TOWN – Sustainability is the priority for vaccine manufacturers that are part of the mRNA technology transfer programme established by the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The programme was launched in 2020 to equip low and middle-income countries (LMIC) to make their own COVID-19 vaccines to address the inequity […] Continue reading -> Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
Sustainability is the Focus of WHO’s mRNA Vaccine Programme as Partners Look Beyond COVID 20/11/2024 Kerry Cullinan CAPE TOWN – Sustainability is the priority for vaccine manufacturers that are part of the mRNA technology transfer programme established by the World Health Organization (WHO) and the Medicines Patent Pool (MPP). The programme was launched in 2020 to equip low and middle-income countries (LMIC) to make their own COVID-19 vaccines to address the inequity […] Continue reading -> Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
Breakthrough Research Promises Shorter Treatment for Multi-Drug-Resistant TB 15/11/2024 Disha Shetty In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored alternative at the World Conference on Lung Health in Bali, Indonesia. The insights came from the endTB-Q trial aimed at finding a simpler, less toxic, shorter regimen for fluoroquinolone-resistant MDR-TB. Fluoroquinolone is a common class of […] Continue reading -> As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
As World’s Health Ministers Meet in Jeddah: Calls for Strong AMR Science Panel With Authority to ‘Challenge’ Sponsors 14/11/2024 Elaine Ruth Fletcher With plans underway for a new “Independent Panel” on Antimicrobial Resistance, endorsed at September’s UN High-Level AMR Meeting, the new body must become a strong scientific authority. It should have the power to “challenge” the agencies that create it and address both human and animal health factors driving drug-resistant pathogens. That was a key message […] Continue reading -> We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
We cannot cure TB without curing TB stigma 30/10/2024 Neelima Sharma In 2021, I lost a close friend to tuberculosis (TB), the world’s most lethal infection. But I cannot say anything else about this friend, where I met him or when we became close. The stigma surrounding tuberculosis is too impenetrable and, unfortunately, it would not be fair to my friend’s family. Still, for me, his […] Continue reading -> Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts
Empowering Africa’s Pharmaceutical Future: The Critical Role of Local API Manufacturing 25/10/2024 Hannes Malan, Gerrit van der Klashorst & Kelly Chibale There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international partnerships can help stimulate African pharma growth, revolutionize API production, and ensure self-sufficiency across the continent in a post-pandemic […] Continue reading -> Posts navigation Older postsNewer posts